1 BTC
=
- USD
Johnson & Johnson
As of May 31, 2026 at 24:02 UTC
Chart
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Market Statistics
Trading Metrics
How to Buy JNJ
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy JNJ
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesJohnson & Johnson announced Phase 3 PROTEUS study results showing ERLEADA® (apalutamide) combined with hormone therapy before and after prostate cancer surgery significantly reduces metastasis/death risk by 20% and increases pathologic complete response rates 9-fold compared to hormone therapy alone in patients with high-risk localized or locally advanced prostate cancer. The findings were presented at ASCO 2026 and published in The New England Journal of Medicine.
Vanguard research suggests value-oriented stocks may outperform tech stocks over the next 5-10 years. The Vanguard High Dividend Yield ETF (VYM), holding 608 large-cap dividend-paying stocks, has delivered 29.5% returns over the past year with a low 0.04% expense ratio and 2.24% dividend yield. The fund offers exposure to quality blue-chip companies like JPMorgan Chase and Johnson & Johnson, though investors should note its concentration risk with Broadcom representing 8% of assets.
With recession concerns rising due to high energy prices and consumer budget tightening, investors should consider adding resilient stocks from consumer staples and healthcare sectors to their portfolios. Four dividend-paying companies recommended for recession-resistant income are Coca-Cola, Procter & Gamble, Johnson & Johnson, and Medtronic, all of which have strong track records of maintaining dividends through economic downturns.
Walmart's stock dropped over 9% following its Q1 earnings due to cautious guidance and concerns about higher fuel costs, despite meeting expectations. However, the article argues this presents a buying opportunity given Walmart's 53-year dividend increase streak, strong growth in Walmart+, advertising revenue (up 36%), and management's optimism about future business potential.
The Vanguard Health Care ETF (VHT) offers broader healthcare sector exposure with lower costs (0.09% expense ratio) and higher dividend yield (1.69%), while the SPDR S&P Biotech ETF (XBI) provides targeted biotech exposure with higher volatility but stronger recent 1-year returns (62.20% vs 13.00%). VHT is better suited for income-seeking investors seeking diversified healthcare exposure, while XBI appeals to aggressive investors seeking biotech-specific growth.
